Get the Stockscreener App
1.80
4.65%
0.08
Silo Pharma Inc stock is traded at $1.80, with a volume of 4.78M.
It is up +4.65% in the last 24 hours and up +115.54% over the past month.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
See More
Previous Close:
$1.72
Open:
$1.91
24h Volume:
4.78M
Relative Volume:
1.62
Market Cap:
$8.07M
Revenue:
$72,100
Net Income/Loss:
$-3.60M
P/E Ratio:
-1.5126
EPS:
-1.19
Net Cash Flow:
$-3.37M
1W Performance:
+65.14%
1M Performance:
+115.54%
6M Performance:
+78.22%
1Y Performance:
+24.45%
1-Day Range:
$1.80
$2.1608
1-Week Range:
$1.51
$3.3699
52-Week Range:
$0.77
$4.50
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma Inc
Sector
Industry
Phone
(718) 400-9031
Address
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2275 | 480.10M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.53 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.65 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.58 | 111.10M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
3.52 | 45.79M | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Stock (SILO) Latest News
Silo Pharma awarded U.S. patent for PTSD treatment - Yahoo Finance
Silo Pharma secures patent for PTSD intranasal treatment By Investing.com - Investing.com Nigeria
Silo Pharma shares soar on patent allowance news By Investing.com - Investing.com South Africa
Silo Pharma shares soar on patent allowance news - Investing.com
Silo Pharma secures patent for PTSD intranasal treatment - Investing.com
Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial - The Manila Times
Silo Pharma Secures Key Patent Protection for PTSD Treatment SPC-15, Strengthens IP Portfolio - StockTitan
SILO Pharma flies high on impending patent for intranasal PTSD drug - Mugglehead
Silo Pharma progresses with PTSD and pain treatments - Investing.com
Silo Pharma Issues Letter to Shareholders Detailing - GlobeNewswire
Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain - Yahoo Finance UK
Silo Pharma initiates pharmacokinetic, tolerability study for SP-26 - Yahoo Finance
Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia - The Manila Times
Silo Pharma Initiates Pharmacokinetic and Tolerability Study for Sp-26 Targeting Chronic Pain and Fibromyalgia - Marketscreener.com
Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain - The Bakersfield Californian
Silo Pharma Launches Groundbreaking Ketamine Implant Study for Chronic Pain Treatment - StockTitan
Silo Pharma partners with Kymanox to develop ketamine implant - MSN
Why Is Silo Pharma Stock Gaining Today? - Benzinga
Silo Pharma advances ketamine implant for chronic pain By Investing.com - Investing.com UK
Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management - GlobeNewswire
Silo Pharma Partners with Kymanox to Develop Novel Ketamine Implant Device | SILO Stock News - StockTitan
Silo Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Silo Pharma stock hits 52-week low at $0.83 amid market challenges - Investing.com Canada
Silo Pharma stock hits 52-week low at $0.83 amid market challenges By Investing.com - Investing.com South Africa
Silo Pharma CEO Eric Weisblum buys $4,625 in company stock - Investing.com
Silo Pharma CEO Eric Weisblum buys $4,625 in company stock By Investing.com - Investing.com Canada
Silo Pharma Inc. Share PriceSILO, RNS News, Articles, Quotes, & Charts (NASDAQ: SILO) - Proactive Investors Australia
Silo Pharma reports promising preclinical results in treating severe stress-related disorders - Proactive Investors UK
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders - The Manila Times
Silo Pharma reports progress in PTSD treatment study - Investing.com
Silo Pharma reports progress in PTSD treatment study By Investing.com - Investing.com UK
Silo Pharma Third Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.21 loss in 3Q 2023) - Yahoo Finance
SILOSilo Pharma, Inc. Latest Stock News & Market Updates - StockTitan
Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - GlobeNewswire
Silo Pharma, Inc. Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - Marketscreener.com
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
Orange Juice (OJX25) Quote - The Globe and Mail
Japan Ice Bank Silo Market By Application - Third Eye News
SILO Pharma (NASDAQ:SILO) Stock Quotes, Forecast and News Summary - Benzinga
Exclusive Come Home Trailer Previews Horror Thriller Movie Featuring Silo Stars - ComingSoon.net
Egypt: General Company for Silos’s profits rise 45.6% YoY in FY2023/24 - ZAWYA
Silvis Materials Awarded $1 Million NSF SBIR Phase II Grant to Reduce Emissions in Packaging and Building - EIN News
FDA Grants Accelerated Approval to Gilead’s Livdelzi for Primary Biliary Cholangitis - The Healthcare Technology Report.
Serpin Pharma and Uniklinikum Erlangen Team Up for a Clinical Trial to Prevent Acute Kidney Injury - EIN News
New Silo Season 2 Character Is Very Closely Copying An Iconic 2000s TV Show - Screen Rant
Roli Mosimann (Swans / Wiseblood / The The) has died - Brooklyn Vegan
SosMula Finally Delivers "SLEEZ RELIGION" - HotNewHipHop
Silo Pharma Inc Stock (SILO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.13%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):